Glycerophospholipid molecular species in platelets and brain tissues - Are platelets a good model for neurons?

Platelets

Volumn 17, Issue 7, 2006, Pages 484-492

  Bakken, Anne Margrethe ^a   Staeffler, Alexander ^b   Jørgensen, Hugo A ^b   Holmsen, Holm ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Neurons; Phospholipids; Platelets

Indexed keywords

DIMETHYLPHOSPHATIDIC ACID; GLYCEROPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CELL SEPARATION; CEREBELLUM; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; THROMBOCYTE; ULTRAVIOLET RADIATION;

ANIMALS; BASAL GANGLIA; BLOOD PLATELETS; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLYCEROPHOSPHOLIPIDS; MODELS, BIOLOGICAL; NEURONS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33750520528     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100600759196     Document Type: Article

References (36)

1. Pletscher A, Laubscher A. Blood platelets as models for neurons: Uses and limitations. J Neural Trans Suppl 1980;16:7-16.
2. Pletscher A, Affolter H. The 5-Hydroxytryptamine receptor of blood platelets. J Neural Trans 1983;57:233-242.
3. Da Prada M, Cesura AM, Launay JM, Richards JG. Platelets as a model for neurons?. Experienta 1988;44:115-126.
4. Pletscher A. Platelets as models: Use and limitations. Experientia 1988;44:152-155.
5. Barrades MA, Mikhailidis DP. The use of platelets as models for neurons: Possible applications to the investigation of eating disorders. Biomed Pharmacotherap 1993;47:11-18.
6. Murphy DL, Donnelly CH. Monamine oxidase in man: Enzyme characteristics in platelets, plasma, and other human tissues. Adv Biochem Psychopharmacol 1974;12:71-85.
7. Buus Lassen J, Lund J, Bechgaard E, Søndergaard I. Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine. Psychopharmalogy 1979;64:149-153.
8. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA VII. Internationale union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
9. z alpha as a pertussis toxin-intensitive G protein in human platelets and megakaryocytes. Blood 1991;78:1247-1253.
10. z, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 2000;97:9984-9999.
11. Canobbio I, Reineri S, Sinigaglia F, Balduini C, Torti M. A role for p38 MAP kinase in platelet acivation by von Willebrand factor. Thromb Haemost 2004;91: 102-110.
12. Campos LS, Leone DP, Relvas JB, Brakebusch C, Fassler R, Suter U, French-Constant C. β1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development 2004;131: 3433-3444.
13. Klawans HL, Goetz CG, Perlik S. Tardive dyskinesia: Review and update. Am J Psychiatry 1980;137:900-908.
14. Ricci A, Bronzetti E, Mannilo F, Mignini F, Morocetti C, Tayebati S, Amenta F. Dopamine receptors in human platelets. Naunyn-Schmieberg's Arch Pharmacol 2001;363: 376-382.
15. Frølich KW, Aarbakke GM, Holmsen H. Chlorpromazine increases the turnover of metabolically active phosphoinositides and elevates the steady-state level of phosphatidylinositol-4-phosphate in human platelets. Biochem Pharmacol 1992;44:2013-2020.
16. Daasvatn KO, Holmsen H. Chlorpromazine and human platelet glycerolipid metabolism: Precursor specificity and significance of drug-platelet interaction time. Biochem Pharmacol 1999;57:1113-1123.
17. Agasøster AV, Tungodden LM, Ceika D, Bakstad E, Sydnes LK, Holmsen H. Chlorpromazine-induced increase in dipalmitoylphosphatidylserine surface area in monolayers at room temperature. Biochem Pharmacol 2001;61:817-825.
18. Agasøster AV, Holmsen H. Chlorpromazine associates with phosphatidylserines to cause an increase in the lipid's own interfacial molecular - role of fatty acyl composition. Biophys Chem 2001;91:37-47.
19. 13C-NMR and differential scanning calorimetry. Biochim Biophys Acta 2000;1464:165-75.
20. 31P solid-state NMR study. Biochim Biophys Acta 2004;1682: 28-37.
21. Agasøster, AV. Role of the phospholipid composition for the drug-membrane and protein-membrane interactions [thesis]. Department of Biochemistry and Molecular Biology, University of Bergen, Norway; 2001. Available from: University of Bergen. ISBN 82-7558-023-4.
22. Han X, Gubitosi-Klug RA, Collins BJ, Gross RW. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: Electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Biochemistry 1996;35:5822-5832.
23. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
24. Arduini A, Peschechera A, Dottori S, Sciarroni AF, Serafini F, Calvani MJ. High performance liquid chromatography of long-chain acylcarnitine and phospholipids in fatty acid turnover studies. J Lipid Res 1996;37:684-689.
25. Fukami MH, Holmsen H. Diacylglycerol elevations in control platelets are unaccompanied by pleckstrin phosphorylation: Implications for the role of diacylglycerol in platelet activation. Eur J Biochem 1995;228: 579-586.
26. Robinson M, Blank ML, Snyder F. Highly unsaturated phospholipid molecular species of rat erythrocyte membranes: selective incorporation of arachidonic acid into phosphoglycerides containing polyunsaturation in both acyl chains. Arch Biochem Biophys 1986;250:271-279.
27. 31P solid state NMR study. Biophys Chem 2005;117:101-109.
28. 1 but not neomycin interfer with the inositol phospholipid metabolism in intact human platelets. FEBS Lett 1990;264:33-36.
29. Holmsen H, Dangelmaier CA. Trifluoperazine enhances accumulation and inhibits phosphohydrolysis of phosphatidate in thrombin-stimulated platelets. Thromb Haemost 1990;64:307-311.
30. Tharmapathy P, Fukami MH, Holmsen H. The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin. Biochem Pharmacol 2000;60: 1267-1277.
31. Takamura H, Narita H, Park HJ, Tanaka K, Matsuurat T, Kito M. Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen. J Biol Chem 1987;262:2262-2269.
32. Mori TA, Codde JP, Vangdongen R, Beilin LJ. New findings in the fatty acid composition of individual platelet phospholipids in man after dietary fish oil supplementation. Lipids 1987;22:744-750.
33. Hsiao LL, Howard RJ, Aikawa M, Taraschi TF. Modification of host cell membrane lipid composition by the intra-erytrocytic human malaria parasite Plasmodium falciparum. Biochem J 1991;274:121-132.
34. Avissar S, Schreibert G, Danon A, Belmaker RH. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 1988;331:440-442.
35. Fauvel J, Chap H, Roques V, Levy-Toledano S, Douste-Blazy L. Biochemical characterization plasma membranes and intracellular membranes isolated from human platelets using Percoll gradients. Biochim Biophys Acta 1986;856:155-164.
36. Lagarde M, Guichardant M, Menashi S, Crawford N. The phospholipid and fatty acid composition of human platelet surface and intracellular membranes isolated by high voltage electrophoresis. J Biol Chem 1982;257:3100-3104.